Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.5c00649
Abstract: Chimeric kinase J-PKAcα represents a potential therapeutic target for fibrolamellar hepatocellular carcinoma (FLHCC). Structure-based design and screening were applied to improve the potency of the marine-derived kinase inhibitor aplithianine A targeting J-PKAcα. Three classes of…
read more here.
Keywords:
aplithianine class;
evolution aplithianine;
class;
kinase ... See more keywords